MedTrace Logo

WATS3D for the Detection of Esophageal Dysplasia

NCT03008980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2021-11-04

No results posted yet for this study

Summary

Patients will be recruited from participating institutions prior to planned routine care EGD with WATS3D brush samples and forceps biopsies. Eligibility will be reviewed and patients who are potentially eligible for the study will be approached regarding the study. If interested, participants will be consented and proceed with routine care EGD. The study coordinator or other research personnel will document information from the routine care endoscopy as part of this research study. Follow-up information collected will include WATS3D cytology and forceps biopsy pathology results from any routine care endoscopy performed during the course of participation in the study, any surgeries received and related to their condition, and any other care received as part of their condition. WATS3D samples will be sent to CDx Diagnostics for analysis.

Conditions

  • Barrett Esophagus
  • Esophageal Dysplasia
  • Esophagus Adenocarcinoma

Interventions

OTHER

Diagnostic Test

Sponsors & Collaborators

  • Rockford Gastroenterology Associates

    collaborator OTHER

  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER

  • Temple University

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • University of Kansas Medical Center

    collaborator OTHER

  • NYU Langone Health

    collaborator OTHER

  • CDx Diagnostics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-01-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03008980 on ClinicalTrials.gov